Comments Regarding Reauthorization of the Over-the-Counter Monograph Drug User Fee Program Share page: Docket Number: FDA-2023-N-3575-0001 Download Document Issues: OTC Medicines Monograph Reform User Fees Related Posts Press Releases and Statements Tennessee Expands Access to OTC Cold & Allergy Medications Containing PSE May 7, 2024 Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024